Complment alimentaire avec dulcorant
L'invention concerne galement l'utilisation de la L-lysine pour potentialiser l'effet de la L-carnitine dans la prparation d'un mdicament destin au traitement des perturbations musculaires lies une hypoexcitabilit ou une hypocontractilit.The invention also relates to the use of L-lysine to potentiate the effect of L-carnitine in the preparation of a medicament intended for the treatment of muscular disturbances linked to hypoexcitability or hypocontractility
S-acetylglutathione has also been shown to decrease TNF-alpha, NF-kappa beta, and F-2 isoprostane.[4,9-12] Additionally, there is mounting evidence that intracellular glutathione levels in antigen-presenting cells (e.g macrophages) may influence the Th1/Th2 cytokine response pattern and promote a balanced immune reaction.*[10]
It also caused less GLP-1R internalization than GLP-1, due to the weaker -arrestin recruitment (30-50% Emax of GLP-1) 30
Similarly, "tirz" emerged for tirzepatide and "sema" for semaglutide
This enhances athletic productivity